Ditchcarbon
  • Customers
  1. Organizations
  2. Omeros Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Omeros Corporation

Company website

Omeros Corporation, a biopharmaceutical company headquartered in the United States, is renowned for its innovative approach to drug development. Founded in 1994, Omeros has made significant strides in the fields of ophthalmology, immunology, and neurology, focusing on the discovery and commercialisation of novel therapeutics. The company’s flagship products, including the FDA-approved Omidria, exemplify its commitment to addressing unmet medical needs with unique formulations that enhance surgical outcomes. Omeros has established a strong market position, bolstered by its proprietary platform technologies and a robust pipeline of drug candidates. With a dedication to advancing patient care, Omeros continues to be a leader in the biopharmaceutical industry, driving forward with a vision of transformative therapies.

DitchCarbon Score

How does Omeros Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Omeros Corporation's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

Omeros Corporation's reported carbon emissions

Omeros Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Omeros Corporation may not have established formal climate initiatives or targets at this time. As the industry increasingly prioritises sustainability, Omeros Corporation's future climate commitments will be crucial for aligning with global standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Omeros Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Omeros Corporation is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Omeros Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Harrow, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Diplomat Pharmacy, Inc.

US
•
Retail trade services, except of motor vehicles and motorcycles; repair services of personal and household goods (52)
Updated 14 days ago

Janssen

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Ocular Therapeutix, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Bausch Health Cos

CA
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Neoleukin Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.10
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy